Emergent Biosolutions (EBS)Director sold ~$126K

~$126K

Approx. value · 18K sh @ $7.09

112K

Holds after · shares reported

Traded

Oct 7, 2026

Filed

Oct 7, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 1, 2026InsiderOfficer sold ~$20K of EBS shares in the open market
2. Oct 7, 2026 · this disclosureInsiderDirector sold ~$126K of EBS shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Emergent Biosolutions

For Emergent Biosolutions, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EBS page.

Other recent filings by Donald W Degolyer, Director

• SEC Form 4 at Emergent Biosolutions (EBS)Aug 13, 2025
• SEC Form 4 at Emergent Biosolutions (EBS)Nov 14, 2024

The full history of Donald W Degolyer, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Emergent Biosolutions

• SEC Form 144Oct 7, 2026
• SEC Form 4Oct 5, 2026
• USAspending.gov award recordJun 4, 2026
• USAspending.gov award recordApr 28, 2026
• USAspending.gov award recordMar 4, 2026
• SEC Form 4Aug 18, 2025

Everything OQRO holds on this company is on its EBS page.